Acquisitions and Acquisition-Related Items (Tables)

9 Months Ended

Jan. 29, 2016

Business Acquisition [Line Items]

Fair Value Measurements, Contingent Consideration, Significant Unobservable Inputs

The recurring Level 3 fair value measurements of contingent consideration include the following significant unobservable inputs:

	Fair Value at
($ in millions)	January 29, 2016	Valuation Technique	Unobservable Input	Range
			Discount rate	11% - 27.2%
Revenue-based payments	$191	Discounted cash flow	Probability of payment	30% - 100%
			Projected fiscal year of payment	2016 - 2025
			Discount rate	0.3% - 5.5%
Product development-based payments	$180	Discounted cash flow	Probability of payment	75% - 100%
			Projected fiscal year of payment	2016 - 2025

Reconciliation of Beginning and Ending Balances of Contingent Consideration Associated with Acquisitions

The following table provides a reconciliation of the beginning and ending balances of contingent consideration associated with acquisitions subsequent to April 24, 2009:

	Three months ended						Nine months ended
(in millions)	January 29, 2016			January 23, 2015			January 29, 2016			January 23, 2015
Beginning Balance	$	368		$	91		$	264		$	68
Purchase price contingent consideration	14			6			149			29
Contingent consideration payments	(2		)	—			(22		)	(5		)
Change in fair value of contingent consideration	(9		)	(4		)	(20		)	1
Ending Balance	$	371		$	93		$	371		$	93

Covidien plc [Member]

Business Acquisition [Line Items]

Fair Value of Assets Acquired and Liabilities Assumed

The fair values of the assets acquired and liabilities assumed in connection with the Transactions are as follows:

(estimated in millions)	January 26, 2015 (as previously reported)		Adjustments			January 26, 2015 (as adjusted)
Accounts receivable	$	1,349	$	—		$	1,349
Inventories	2,222		(3		)	2,219
Other current assets	2,949		232			3,181
Property, plant, and equipment	2,354		(61		)	2,293
Goodwill	29,586		393			29,979
Intangible assets	26,265		(55		)	26,210
Other assets	747		14			761
Total assets acquired	65,472		520			65,992
Short-term borrowings	1,011		—			1,011
Other current liabilities	2,331		103			2,434
Long-term debt	4,623		—			4,623
Long-term deferred tax liabilities	4,736		9			4,745
Other long-term liabilities	2,783		408			3,191
Total liabilities assumed	15,484		520			16,004
Net assets acquired	$	49,988	$	—		$	49,988

Acquisitions 2016 [Member]

Business Acquisition [Line Items]

Fair Value of Assets Acquired and Liabilities Assumed

The fair values of the assets acquired and liabilities assumed during the nine months ended January 29, 2016 are as follows:

(in millions)	Twelve, Inc.		RF Surgical Systems, Inc.		Medina Medical		All Other		Total
Other current assets	$	60	$	43	$	11	$	40	$	154
Property, plant, and equipment	—		3		—		5		8
IPR&D	192		—		122		143		457
Other intangible assets	—		115		—		184		299
Goodwill	301		132		126		238		797
Other assets	—		2		—		15		17
Total assets acquired	553		295		259		625		1,732
Current liabilities	37		28		6		21		92
Long-term deferred tax liabilities, net	44		27		34		56		161
Other liabilities	—		—		—		2		2
Total liabilities assumed	81		55		40		79		255
Net assets acquired	$	472	$	240	$	219	$	546	$	1,477

Acquisitions 2015 [Member]

Business Acquisition [Line Items]

Fair Value of Assets Acquired and Liabilities Assumed

The fair values of the assets acquired and liabilities assumed from acquisitions during fiscal year 2015, other than the Covidien acquisition, are as follows:

(in millions)	NGC Medical S.p.A.		Sapiens Steering Brain Stimulation		All Other		Total
Other current assets	$	55	$	3	$	12	$	70
Property, plant, and equipment	15		1		2		18
IPR&D	—		30		39		69
Other intangible assets	159		—		157		316
Goodwill	197		170		108		475
Other assets	3		3		49		55
Total assets acquired	429		207		367		1,003
Current liabilities	34		4		6		44
Long-term deferred tax liabilities, net	51		—		66		117
Other liabilities	4		—		—		4
Total liabilities assumed	89		4		72		165
Net assets acquired	$	340	$	203	$	295	$	838